Aidan Riley

Gardn Biosciences

BIOGRAPHY

Aidan Riley is the founder and CEO of Gardn Biosciences, building generative RNA design technologies to accelerate therapeutic development. He developed data-efficient machine learning frameworks for RNA design and methods for constraint-aware sequence optimization, working at the intersection of synthetic biology and AI.

Aidan focuses on programmable control of RNA therapeutics, combining computational innovations with biological engineering to advance next-generation treatment platforms. His work bridges advanced AI techniques with practical therapeutic applications to drive scalable RNA-based solutions.